SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-12-058109
Filing Date
2012-02-14
Accepted
2012-02-14 06:26:16
Documents
1
Group Members
AFT LEVERAGED MASTER FUND, LTD.ATLAS FUNDAMENTAL TRADING , L.P.ATLAS FUNDAMENTAL TRADING FUND, LTD.ATLAS FUNDAMENTAL TRADING LEVERAGED FUND, L.P.ATLAS FUNDAMENTAL TRADING MASTER FUND LTD.ATLAS GLOBAL INVESTMENTS, LTD.ATLAS GLOBAL JAPAN UNIT TRUSTATLAS GLO

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G, AMENDMENT NO. 1 d298383dsc13ga.htm SC 13G/A 409837
  Complete submission text file 0001193125-12-058109.txt   412278
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78786 | Film No.: 12602315
SIC: 2834 Pharmaceutical Preparations

Mailing Address 181 W MADISON STE 3600 CHICAGO IL 60602
Business Address 181 W MADISON STE 3600 CHICAGO IL 60602 3124992999
BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A